COVID-19: guidance for sampling and for diagnostic laboratories

Information for clinical diagnostic laboratories regarding safety, sampling and packaging specimens associated with COVID-19.



These documents provide guidance to clinical diagnostic laboratories on the handling and processing of specimens for the diagnosis of COVID-19, and covers safety, laboratory investigations as well as sample requirements.

Use Form (E28) for requesting testing for COVID-19.

There may be further information specific to each country in the United Kingdom, as this guidance was written by Public Health England primarily for an English health professional audience. To see if country specific information is available, please refer to Health Protection Scotland, Public Health Wales, or Public Health Agency in Northern Ireland.

Published 15 January 2020
Last updated 17 February 2020 + show all updates
  1. Update to list of laboratories in the 'how to arrange laboratory testing' document.

  2. Updated list of laboratories in the 'how to arrange laboratory testing' document.

  3. Update to designated laboratories.

  4. Revisions to safe handling and processing for laboratories, and added video describing sample packaging.

  5. Updated guidance for laboratory investigations and sample requirements.

  6. Update to guidance on how to arrange testing.

  7. Updated information on packaging and transport of samples.

  8. Updated posters and text editions.

  9. Updated information on process for sending samples to PHE.

  10. Clarification to 'who to call to request testing'.

  11. Added clarification of sampling and packaging, with new and revised posters.

  12. Added information about biosafety levels.

  13. Update to risk assessment and point of care tests.

  14. Added laboratory specimen and packing requirements and poster.

  15. Added who to call to request laboratory testing document.

  16. Added 'Laboratory investigations and sample requirements' document and algorithm.

  17. First published.